Hot Features
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, ant... Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business. The company also engages in key pharmaceutical intermediates, APIs, and formulations activities. The company was founded in 1998 and is headquartered in Tianjin, China. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.66 | 11.5586690018 | 5.71 | 6.37 | 5.71 | 120 | 5.98615063 | DR |
| 4 | 0.66 | 11.5586690018 | 5.71 | 6.37 | 5.71 | 120 | 5.98615063 | DR |
| 12 | 1.37 | 27.4 | 5 | 6.37 | 5 | 80 | 5.56946792 | DR |
| 26 | 3.169918 | 99.0573991541 | 3.200082 | 6.37 | 3.200082 | 53 | 5.56946792 | DR |
| 52 | 3.169918 | 99.0573991541 | 3.200082 | 6.37 | 3.200082 | 28 | 5.56946792 | DR |
| 156 | 3.17 | 99.0625 | 3.2 | 6.37 | 3.2 | 82 | 3.90784946 | DR |
| 260 | 3.17 | 99.0625 | 3.2 | 6.37 | 3.2 | 82 | 3.90784946 | DR |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.